Atara Biotherapeutics (ATRA) Financials

Atara Biotherapeutics Inc (ATRA) is a biotechnology company focused on developing therapies for patients with serious medical conditions. The company's financials provide important insights into its performance and financial health. The income statement is a financial statement that shows the company's revenues, expenses, and net income over a specific period. It provides information about the company's ability to generate profit from its operations. In the case of Atara Biotherapeutics, the income statement reflects the company's revenue from the sale of its therapeutics, as well as its expenses such as research and development costs, marketing expenses, and general administrative costs.

Another key financial metric is EBIT (earnings before interest and taxes), which measures the company's profitability before accounting for interest and taxes. EBITDA (earnings before interest, taxes, depreciation, and amortization) is a similar metric that adds depreciation and amortization to EBIT. These metrics provide a clearer picture of a company's operating performance and its ability to generate cash flows from its core operations. Gross profit is another important financial metric that shows the amount of revenue left after deducting the cost of goods sold. It indicates the company's efficiency in managing its production costs and pricing its products.

Net income from stockholders represents the portion of the company's profit that is attributable to its stockholders. It is calculated by subtracting taxes, interest, and other expenses from the company's net income. Total revenue is the sum of all the revenue generated by the company, including revenue from product sales, licensing agreements, and other sources. It provides an overall measure of the company's sales performance.

Moving to the balance sheet, it provides a snapshot of the company's financial condition at a specific point in time. It includes information about the company's assets, liabilities, and stockholders' equity. Cash equivalents refer to highly liquid assets that can be readily converted into cash, such as short-term investments and marketable securities. Net debt represents the total debt of the company minus its cash equivalents and is a measure of its overall indebtedness. Stockholders' equity represents the residual interest in the assets of the company after deducting its liabilities.

Total assets represent the total value of the company's assets, including both tangible assets such as property and equipment, and intangible assets such as patents and trademarks. Total debt includes both short-term and long-term debt owed by the company. Total liabilities represent the company's obligations to creditors and other stakeholders. Understanding the balance sheet is crucial for assessing the company's financial stability and its ability to meet its obligations.

Cash flow refers to the movement of money into and out of the company. Operating cash flow measures the cash generated or used by a company's core operations, while investing cash flow reflects the cash spent on acquiring or disposing of assets. Financing cash flow includes cash flows from borrowing or repaying debt, issuing or repurchasing stock, and payment of dividends. Free cash flow is the cash flow remaining after deducting capital expenditures from operating cash flow. It represents the amount of cash available for distribution to investors or reinvestment in the business.